BPC-157/TB-500 Blend

A synergistic blend combining BPC-157 and TB-500 for studying tissue repair and regeneration pathways.

Supplied as a research-use-only preparation from a cGMP-compliant, ISO-certified facility and guaranteed to a minimum of 99% purity. Each lot is submitted for independent third-party analysis, and the certificate of analysis is tied to the lot code printed on the vial you receive.

Not for human or animal consumption. This compound is intended strictly for in-vitro laboratory and scientific research use. It is not approved by the FDA and is not for medical, diagnostic, or therapeutic use.

Form

Lyophilized powder

Lyophilized storage

Keep dry and sealed. Store per the vial label; protect from light.

Solvent

Bacteriostatic water (0.9% benzyl alcohol)

Reconstituted storage

Refrigerate after reconstitution. Do not shake — swirl to dissolve.

Handling

Allow the vial to reach room temperature before opening to limit condensation.

Category

Regenerative Research

Class

Synergistic blend combining BPC-157 and TB-500

SKU

BPCTB-10

Purity

≥99% guaranteed

BPC-157

C62H98N16O22 · 1419.5 g/mol

TB-500

C212H350N56O78S · 4963 g/mol

Origin

Manufactured in the USA

Availability

In stock

BPC-157 is a synthetic pentadecapeptide corresponding to a partial sequence of a protein found in human gastric juice. TB-500 corresponds to the actin-binding region of thymosin β4, a naturally occurring 43-amino-acid peptide.

Published work examines these compounds in models of angiogenesis, granulation-tissue formation, fibroblast migration, and tendon and ligament repair. The great majority of BPC-157 data is preclinical and rodent-derived; controlled human trials are limited.

On the evidence base. One of the references below is a 2025 narrative review that is explicitly critical of the BPC-157 evidence base. It is included deliberately — a reference list that only points one direction is marketing, not literature.